These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 11565319)

  • 21. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.
    Mousa SA; Bergh JJ; Dier E; Rebbaa A; O'Connor LJ; Yalcin M; Aljada A; Dyskin E; Davis FB; Lin HY; Davis PJ
    Angiogenesis; 2008; 11(2):183-90. PubMed ID: 18080776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiogenesis is confined to the transient period of VEGF expression that follows adenoviral gene delivery to ischemic muscle.
    Gounis MJ; Spiga MG; Graham RM; Wilson A; Haliko S; Lieber BB; Wakhloo AK; Webster KA
    Gene Ther; 2005 May; 12(9):762-71. PubMed ID: 15772688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic angiogenesis in peripheral arterial disease: can biotechnology produce an effective collateral circulation?
    Collinson DJ; Donnelly R
    Eur J Vasc Endovasc Surg; 2004 Jul; 28(1):9-23. PubMed ID: 15177227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiogenesis in the human heart: gene and cell therapy.
    Tirziu D; Simons M
    Angiogenesis; 2005; 8(3):241-51. PubMed ID: 16308736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiogenic therapy for coronary artery and peripheral arterial disease.
    Hughes GC; Annex BH
    Expert Rev Cardiovasc Ther; 2005 May; 3(3):521-35. PubMed ID: 15889979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding the biology of angiogenesis: review of the most important molecular mechanisms.
    Otrock ZK; Mahfouz RA; Makarem JA; Shamseddine AI
    Blood Cells Mol Dis; 2007; 39(2):212-20. PubMed ID: 17553709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth factors for therapeutic angiogenesis in peripheral arterial disease.
    Jones WS; Annex BH
    Curr Opin Cardiol; 2007 Sep; 22(5):458-63. PubMed ID: 17762548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of an oversulfated exopolysaccharide on angiogenesis induced by fibroblast growth factor-2 or vascular endothelial growth factor in vitro.
    Matou S; Colliec-Jouault S; Galy-Fauroux I; Ratiskol J; Sinquin C; Guezennec J; Fischer AM; Helley D
    Biochem Pharmacol; 2005 Mar; 69(5):751-9. PubMed ID: 15710353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.
    Pradeep CR; Sunila ES; Kuttan G
    Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changing the logic of therapeutic angiogenesis for ischemic disease.
    Emanueli C; Madeddu P
    Trends Mol Med; 2005 May; 11(5):207-16. PubMed ID: 15882608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses.
    Rissanen TT; Markkanen JE; Gruchala M; Heikura T; Puranen A; Kettunen MI; Kholová I; Kauppinen RA; Achen MG; Stacker SA; Alitalo K; Ylä-Herttuala S
    Circ Res; 2003 May; 92(10):1098-106. PubMed ID: 12714562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A relationship between vascular endothelial growth factor, angiogenesis, and cardiac repair after muscle stem cell transplantation into ischemic hearts.
    Payne TR; Oshima H; Okada M; Momoi N; Tobita K; Keller BB; Peng H; Huard J
    J Am Coll Cardiol; 2007 Oct; 50(17):1677-84. PubMed ID: 17950150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neovascularization after ischemic stroke].
    Hu X; Zhou D
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun; 21(3):516-9. PubMed ID: 15250170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT).
    Hedman M; Hartikainen J; Syvänne M; Stjernvall J; Hedman A; Kivelä A; Vanninen E; Mussalo H; Kauppila E; Simula S; Närvänen O; Rantala A; Peuhkurinen K; Nieminen MS; Laakso M; Ylä-Herttuala S
    Circulation; 2003 Jun; 107(21):2677-83. PubMed ID: 12742981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review of the effects of anti-angiogenic compounds on the epiphyseal growth plate.
    Hall AP; Westwood FR; Wadsworth PF
    Toxicol Pathol; 2006; 34(2):131-47. PubMed ID: 16537292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in growth factor delivery for therapeutic angiogenesis.
    Said SS; Pickering JG; Mequanint K
    J Vasc Res; 2013; 50(1):35-51. PubMed ID: 23154615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic angiogenesis: angiogenic growth factors for ischemic heart disease.
    Henning RJ
    Future Cardiol; 2016 Sep; 12(5):585-99. PubMed ID: 27420190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic neovascularization for peripheral arterial diseases: advances and perspectives.
    Zhou B; Poon MC; Pu WT; Han ZC
    Histol Histopathol; 2007 Jun; 22(6):677-86. PubMed ID: 17357097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiogenesis and the ischaemic heart.
    Tabibiazar R; Rockson SG
    Eur Heart J; 2001 Jun; 22(11):903-18. PubMed ID: 11428814
    [No Abstract]   [Full Text] [Related]  

  • 40. Approaches to therapeutic angiogenesis for ischemic heart disease.
    Johnson T; Zhao L; Manuel G; Taylor H; Liu D
    J Mol Med (Berl); 2019 Feb; 97(2):141-151. PubMed ID: 30554258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.